Expert Patient Self-management Programme Versus Usual Care in Bronchiectasis

Belfast Health and Social Care Trust

Status: Completed

Conditions: Bronchiectasis

Treatments: Behavioral: Usual care; Behavioral: Expert Patient Programme

Study type: Interventional

Funder types: Other

Identifiers

NCT01117493

06054JB-A

Details and patient eligibility

About

The aim of this exploratory randomized controlled trial was to investigate the efficacy of a disease specific Expert Patient Programme compared to usual care in patients with bronchiectasis. Hypothesis: Disease specific EPP will increase self efficacy compared to usual care.

Enrollment: 64 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients (>18 years) with a primary diagnosis of bronchiectasis based on a respiratory physician's assessment including a computed tomography scan were included in the study

Exclusion criteria

• Primary diagnosis of cystic fibrosis
• Patients with methicillin-resistant Staphylococcus aureus infection
• Patients with any condition that would have an impact on the assessment procedures (e.g. sensory impairment, pregnancy, language barriers)
• Any factor that would prevent adherence to the self-management programme.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

64 participants in 2 patient groups

Usual care

Other group

Description:

Usual care included reviews at a specialist respiratory clinic on a three monthly basis to monitor spirometry, inflammatory blood markers and sputum microbiology. The patients were prescribed inhaled therapy and antibiotics if required, and treatment adjusted to the needs of the patient as necessary, including hospital admission.

Treatment:

Behavioral: Usual care

Expert Patient Programme

Experimental group

Description:

Receives a disease specific Expert Patient Programme in addition to usual care. The disease specific Expert Patient Programme was delivered one session per week (lasting 2½ hours) for eight weeks and included 2 weeks disease specific education followed by 6 weeks standardised Expert Patient Programme.

Treatment:

Behavioral: Expert Patient Programme